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Feasibility of a Randomized Clinical Trial
for Treatment of Femoroacetabular
Impingement of the Hip
Gloria N. Boye,* BA, Kerri Murray,* MPH, John C. Clohisy,† MD, and Young-Jo Kim,*‡ MD, PhD
Investigation performed at Boston Children’s Hospital, Boston, Massachusetts, USA,
and Washington University School of Medicine, St Louis, Missouri, USA
Background: Symptomatic femoroacetabular impingement (FAI) is currently corrected by surgery. However, it is possible that
nonsurgical treatment could resolve symptomatic FAI in some patients; thus, uncertainty about the necessity of surgical treatment
exists. The current equipoise concerning FAI treatment presents an opportunity to conduct a randomized controlled trial (RCT) of
surgical and nonsurgical treatment options. Given the unique challenge of adequate patient enrollment in RCTs, it is important that
a preliminary study is done to appraise the feasibility of conducting an RCT.
Purpose: To estimate enrollment rates of a planned future RCT to compare surgical and nonsurgical treatments for symptomatic
FAI and to identify factors associated with patients’ willingness to participate in the randomized trial.
Study Design: Cross-sectional study; Level of evidence, 4.
Methods: Patients diagnosed with FAI at 2 orthopaedic centers were presented with a hypothetical randomized trial comparing 2
treatment options for FAI. All patients completed forms providing information regarding their willingness to participate and
treatment preferences.
Results: A total of 75 patients participated in the study: 53 and 22 from 2 centers, respectively. Twenty-eight percent indicated
absolute willingness to participate in the trial, 40%were probably willing or unsure, and 32%were definitely not willing; 18.7% had
a strong preference for surgery while 2.7% strongly preferred nonsurgical treatment. The majority (78.6%) had no strong pre-
ference for either treatment arm. There were correlations between treatment preferences and willingness to participate. Patients
with a strong treatment preference and/or a preference for surgery were less likely to be willing to participate.
Conclusion: The study findings suggest that sufficient patient accrual for a randomized trial of FAI treatment is currently feasible
while equipoise still exists among patients and surgeons.
Keywords: femoroacetabular impingement (FAI); randomized clinical trial; feasibility study; surgical treatment; nonsurgical
treatment
Femoroacetabular impingement (FAI) is a pathologic
mechanical condition of increasing interest because of its
high prevalence and role in the development of osteoar-
thritis (OA) of the hip.2 It is characterized by a femoral
head-neck deformity (cam) that leads to eccentric loading
within the joint or an acetabular overcoverage deformity
(pincer) that leads to restriction of hip motion, or a com-
bination of the 2 (mixed) deformities. A cross-sectional
study done by Reichenbach et al10 indicated that approx-
imately 25% of young male adults have the FAI defor-
mity. Several epidemiologic studies also point to the
importance of this deformity in the development of hip
OA.1,5,9 It is therefore apparent that investment in
advancing treatment options for FAI will not only relieve
symptoms but also potentially decrease the progression
of hip OA.2
Femoroacetabular impingement represents a varied
spectrum of disease patterns among a diverse patient pop-
ulation requiring a range of evolving treatment strategies.3
Because of the complexity of the FAI deformity, there exists
much variability in treatment options. Increasing evidence
suggests the efficacy of surgical procedures in correcting
the deformity and relieving symptoms. Nonetheless, lower
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level evidence studies form the main source of this evi-
dence. Cohort studies have also suggested that nonsurgical
treatment can relieve symptomatic FAI.4,8 At this time,
surgeon equipoise persists, and payers remain doubtful of
the effectiveness of surgery,2 providing us the opportunity
and the need to perform randomized controlled trials.
The hierarchy of clinical research is established,7 and ran-
domized controlled trials (RCTs) are considered the highest
level of evidence. However, RCTs comparing surgical and
nonsurgical treatments can present particular obstacles
relative to the study design and feasibility. One major disad-
vantage is the potential for low patient enrollment, which
should be thoroughly considered while planning an RCT.
An RCT feasibility analysis was conducted by Creel
et al3 prior to their undertaking of the Meniscal Tear
in Osteoarthritis Research (MeTeOR) trial. They utilized
a method proposed by Halpern6 called prospective prefer-
ence assessment, which helps mimic recruitment and
predict enrollment rates. We also undertook this assess-
ment by presenting a hypothetical randomized trial of
arthroscopic and nonsurgical therapy for managing FAI.
The primary purpose of our feasibility study was to esti-
mate the proportion of FAI patients who would be will-
ing to enroll in the trial. Other aims were to determine
the appropriate set of enrollment criteria defining the
type of FAI deformity to be represented in the cohort for
the forthcoming RCT and identify factors associated with
willingness to participate. This analysis will enable us
to effect needed modifications in trial design and recruit-
ment strategy.
METHODS
On receiving institutional review board approval, patients
were recruited from 2 large academic referral centers: one
primarily an adult (center A) and the other a primarily
pediatric care center (center B). Each center took a differ-
ent approach in creating a cohort of subjects for the feasi-
bility study. Center A enrolled all patients who had been
diagnosed with FAI deformity. Center B had additional
eligibility criteria for recruitment to participate in the
study: a minimummodified Dunn lateral view alpha angle
of 60 as evidence of cam-type impingement, 15 of hip
internal rotation in 90 of flexion, a pain score of at least
5 of 20 on the Western Ontario andMcMaster Universities
Osteoarthritis Index (WOMAC) 5-item pain scale, and at
least 3 months of symptoms secondary to FAI. All subjects
recruited from both centers were 18 years or older. Those
with a history of hip surgery, inflammatory arthritis, ske-
letal dysplasia, or neuromuscular disorders were not
included in the study.
A research coordinator approached eligible patients at
clinic visits either before or after consultation with the sur-
geon to introduce the concept of the feasibility study and
administer the study survey. We used a standardized script
that explained the design of a hypothetical randomized trial
comparing 2 treatment options for FAI: surgical (arthro-
scopy) and nonsurgical (management with physical therapy
and anti-inflammatories). The script also mentioned that
while FAI is usually treated by surgery, nonoperative
treatment was also a possibility that lacked significant
investigation. A flowchart helped the patient follow the
randomization process.
After establishing patients’ understandings of both the
feasibility and hypothetical studies, we invited them to
complete the survey form. This form queried patients’ will-
ingness to participate in a randomized trial, treatment
preferences, and factors influencing their choices. We used
a 5-point scale to categorize willingness to participate: defi-
nitely, probably, unsure, probably not, and definitely not.
Patients were then asked to indicate as many factors out
of 9 options that influenced their decision about participat-
ing (Table 1). Treatment preference was categorized into
the following: definitely nonsurgical, probably nonsurgical,
unsure/no preference, probably surgery, and definitely sur-
gery. Again, we gave opportunity to select reasons for their
preference (Table 1). Demographic data were collected, and
WOMAC pain scores were documented from questionnaires
they completed as part of standard procedure for their clin-
ical care.
For analysis, patients’ willingness to participate in the
described trial was grouped into 3 categories: definitely
willing, probably willing or unsure, and probably or defi-
nitely not willing. We evaluated the association of age, sex,
education, race, employment, and pain with willingness to
participate. The continuous factors, age andWOMAC pain
score, were compared across the categorical variables
using 1-way analysis of variance and independent t tests
as appropriate. We employed the chi-square and Fisher
exact tests in assessing relations between categorical fac-
tors and the variables. We also used these tests to see how
willingness to participate in a randomized trial correlated
TABLE 1
Possible Influential Factors Presented





1. I don’t want to
participate in research
2. I don’t want to be
randomized
3. I already know that I
want surgery
4. I am not willing to wait
6months to have surgery




6. I already know that I
don’t want surgery
7. I don’t believe surgery
will make me better
8. I want to contribute to
research
9. Getting paid
1. How my physician thinks my
hip-related problem should be
treated
2. How my family thinks my hip-
related problem should be
treated
3. The advice and experience of my
friends
4. My ability to go to work or go
about my daily activities
5. Not wanting to be a burden on
my family
6. Worries about money
7. Concerns about the potential
surgical risks
8. Worries about side effects or
risks of addiction to pain
medication
9. Nonoperative treatment has not
been effective for me
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with treatment preference. Significance was defined as P
< .05. Both center and combined specific analyses were
done. We determined the frequency of influential factors
of willingness and treatment preferences within the
cohort of patients from both centers who met the stricter
inclusion criteria. Statistical analysis was performed
using SPSS version 19.0 (IBM Corp) and Microsoft Excel.
RESULTS
Center A
At center A, 53 patients were identified to be eligible, and
all agreed to participate in the feasibility study. Of the 53
who participated, 51% were female and 90.6% were white.
The mean age was 33.4 ± 10.1 years, and the mean
WOMAC pain score (range, 0-20) was 6.8 ± 3.9. Concern-
ing willingness to participate in the hypothetical rando-
mized trial, 34% (n ¼ 18) were definitely interested in
participating, 34% (n ¼ 18) were probably willing, 11.3%
(n ¼ 6) were unsure, 13.2% (n ¼ 7) were probably not will-
ing, and 7.5% (n ¼ 4) were definitely not going to partici-
pate in the randomized trial. None of the demographic
identifiers assessed nor WOMAC pain score were found
to significantly correlate with willingness to participate,
as shown in Table 2.
For treatment preferences, 15.1% (n ¼ 8) absolutely
wanted surgery while 3.8% (n ¼ 2) had strong preference
for nonsurgical options; 28.3% (n ¼ 15) said they probably
would like to have surgery, 15.1% (n ¼ 8) probably wanted
nonsurgical treatment, and 37.7% (n ¼ 20) were unsure.
There were strong associations between treatment prefer-
ence and willingness to participate (Table 3). Six of 10
(60%) subjects with a strong preference of treatment were
unwilling to participate compared with 5 of 43 (11.6%) of
those with no strong preference who were also not willing
to participate in the hypothetical trial (chi-square for trend,
P ¼ .04). Five of 24 (20.8%) subjects who were leaning
toward surgical treatment were definitely willing to partic-
ipate, while 13 of 29 (44.8%) with no preference for surgery
expressed certainty about participating in the study (chi-
square for trend, P ¼ .02).
If the more specific inclusion criteria used at center B
were applied to the center A cohort, 30.2% (16/53) of the
subjects from center A were eligible. Of the 16, 25% (n ¼
4) were sure they would participate in the randomized trial,
50% (n ¼ 8) said they probably would participate, and 25%
(n ¼ 4) were unwilling to be part of the trial.
TABLE 2









(n ¼ 53) P Value
Age, y, mean ± SD 37.61 ± 10.44 32.13 ± 9.6 29.27 ± 8.92 33.40 ± 10.11 .067
Sex
Male 8 (44.4) 10 (41.7) 8 (72.7) 26 (49.1)
Female 10 (55.6) 14 (58.3) 3 (27.3) 27 (50.9) .2
Race
Nonwhite 3 (16.7) 1 (4.3) 0 (0) 4 (7.7)
White 15 (83.3) 22 (95.7) 11 (100) 48 (92.3) .19
Education
High school or lower 2 (11.1) 5 (20.8) 2 (18.2) 9 (17)
Some college or technical college 6 (33.3) 3 (12.5) 4 (36.4) 13 (24.5)
College graduate 10 (55.6) 16 (66.7) 5 (45.5) 31 (58.5) .43
Employment status
Full-/part-time work 14 (77.8) 19 (79.2) 5 (45.5) 38 (71.7)
Not working 4 (22.2) 5 (20.8) 6 (54.5) 15 (28.3) .094
WOMAC pain score, mean ± SD 8.41 ± 3.392 6.04 ± 4.28 5.82 ± 3.37 6.78 ± 3.92 .109
aResults are reported as n (%) unless otherwise indicated. WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
TABLE 3









(n ¼ 53) P Value, w2 for Trend
Definite preference 3 (16.7) 1 (4.2) 6 (54.5) 10 (18.9)
No definite preference 15 (83.3) 21 (87.5) 5 (45.5) 41 (77.4) .039
Surgical preference 5 (27.8) 11 (45.8) 8 (72.7) 24 (45.3)
No surgical preference 13 (72.2) 13 (54.2) 3 (27.3) 29 (54.7) .02
aResults are reported as n (%).
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Center B
At center B, 121 patients were screened for eligibility, with
18% (22/121) meeting inclusion criteria for enrollment. Age
(24% were younger than 18 years), cut-off alpha angle
(22%), and WOMAC pain score (11%) were major factors
that accounted for exclusion. All 22 eligible patients agreed
to complete the feasibility study. In this group, 72.7% were
male and 92.3% white. The mean age was 32 ± 12.8 years,
and the mean pain score was 8 ± 5.2. The percentage of this
cohort definitely willing to be part of the randomized study
was 13.6% (3/22). Five (22.7%) of them expressed possible
interest in participating, and 1 subject was not sure. On the
other end of the spectrum, 36.4% (n¼ 8) indicated they prob-
ably would not participate, and 22.7% (n¼ 5) were sure they
would not participate. Neither pain nor the demographic fac-
tors examined related with willingness to participate in this
group as well (Table 4). There was no subject in this group
who surely wanted nonsurgical treatment. Three (13.6%)
subjects indicated they would possibly opt for nonsurgical
treatment, while 4 (18.2%) showed likely preference for sur-
gery, 6 (27.3%) specified absolute preference for surgery, and
9 (40.9%) were unsure. The relationship between treatment
preference and willingness to participate was not found to be
statistically significant for this group (Table 5).
Combined
The center A and B cohorts meeting the stricter inclusion
criteria were combined to provide a total of 38 subjects:
16 from center A and 22 from center B. A basic epidemiolo-
gical description of this cohort showed 63% male, 87%
white, and mean age of 31.8 ± 9.3 years. Within this group,
18% expressed strong interest in participating in the
hypothetical randomized trial, 34% indicated they were
likely to participate, 3% were unsure, 26% said probably
not, and 18% stated absolute unwillingness to be part of the
trial (Figure 1).
A descriptive analysis of the most important factors
influencing willingness to participate in the combined
cohorts meeting the stricter inclusion criteria were (1) I
don’t want to be randomized (36%), (2) I know I want sur-
gery (34%), (3) I want to contribute to research (24%), (4)
I don’t believe physical therapy and anti-inflammatories
will help (21%), and (5) I am not willing to wait 6 months
to have surgery (21%).
Regarding treatment preference, 26% definitely wanted
surgery, 16% probably wanted surgery, 13% probably
wanted nonoperative treatment, 5% stated definite prefer-
ence for nonsurgical treatment, and 40% were ambivalent.
The physician’s recommendation was the most popular
TABLE 4









(n ¼ 22) P Value
Age, y, mean ± SD 32.00 ± 12.77 35.50 ± 9.65 28.31 ± 8.7 30.77 ± 9.6 .32
Sex
Male 2 (66.7) 5 (83.3) 9 (69.2) 16 (72.7)
Female 1 (33.3) 1 (16.7) 4 (30.8) 6 (27.3) .79
Race
Nonwhite 2 (66.7) 6 (100) 10 (76.9) 18 (81.8)
White 1 (33.3) 0 (0) 3 (23.1) 4 (18.2) .37
Education
High school or lower 1 (33.3) 0 (0) 2 (15.4) 3 (13.6)
Some college or technical college 1 (33.3) 2 (33.3) 7 (53.8) 10 (45.5)
College graduate 1 (33.3) 4 (66.7) 4 (30.8) 9 (40.9) .47
Employment status
Full-/part-time work 3 (100) 5 (83.3) 6 (46.2) 14 (63.6)
Not working 0 (0) 1 (16.7) 7 (53.8) 8 (36.4) .11
WOMAC pain score, mean ± SD 8.00 ± 5.20 7.50 ± 2.81 9.85 ± 4.26 8.95 ± 4.01 .47
aResults are reported as n (%) unless otherwise indicated. WOMAC, Western Ontario and McMaster Universities Osteoarthritis Index.
TABLE 5









(n ¼ 22) P Value, w2 for Trend
Definite preference 2 (66.7) 0 (0) 4 (30.8) 6 (27.3)
No definite preference 1 (33.3) 6 (100) 9 (69.2) 16 (72.7) .6
Surgical preference 2 (66.7) 0 (0) 8 (61.5) 10 (45.5)
No surgical preference 1 (33.3) 6 (100) 5 (38.5) 12 (54.5) .4
aResults are reported as n (%).
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influential factor for treatment preference, with 71%
choosing this option. Other notable factors were functional
ability (45%) and ineffectiveness of prior nonsurgical man-
agement (24%).
DISCUSSION
Our 2-center study was designed to allow us to estimate
enrollment rates for a future randomized controlled trial
of arthroscopic treatment versus nonsurgical management
of FAI and also identify the group of FAI patients with
whom the trial would be feasible. One center recruited
patients to create a cohort representative of the heterogene-
ity of FAI deformities while the other took a more selective
method forming a group in which one form of FAI morphol-
ogy was predominant. The main advantage of the former
approach is a higher proportion of eligible patients, as evi-
denced in our results whereas the latter allows for a more
focused research study. These 2 factors must be weighed
carefully when designing an RCT with regard to the feasi-
bility of enrolling a sufficient number of subjects versus a
more defined cohort perhaps producing a more consistent
result. Our study provides the range of subjects that must
be screened for both approaches to designing the inclusion
criteria.
Our different enrollment criteria introduced some limita-
tions to our feasibility study. The pediatric center’s recruit-
ing strategy resulted in the exclusion of 24% of eligible
patients because they were younger than 18 years. How-
ever, since FAI is increasingly diagnosed in adolescents,
extending the age range to include skeletally mature
patients younger than 18 years may increase enrollment
numbers. The stricter eligibility criteria used at the pedia-
tric center also excluded many patients from participating
in the study on the basis of the type of FAI deformity,
thereby making it difficult to ascertain the enrollment
potential from that center if the criteria were altered to
expand the pool of eligible patients.
Another limitation of our feasibility study design was
that it precluded the analysis of the effect of each center’s
research history and environment on willingness to partic-
ipate. It is possible that varying levels of patient experience
with clinical research or staff experience in recruitment at
different centers is associated with patients’ willingness to
participate in the RCT. Our results showed a higher propor-
tion of patients from the pediatric center (center B) not will-
ing to participate in the future trial. This may be attributed
to differences in how each center presented the research
plan to patients, or it may just be due to regional variations
in patient populations we did not account for (Figure 1). All
the same, a multicenter study design will ensure that one
center’s shortage of willing study participants is offset by
a significant number of participating patients from other
centers.
Our findings suggest that enrollment for our planned
randomized trial may benefit if more relaxed inclusion cri-
teria were used. We conducted a subanalysis to evaluate
the potential effect of relaxing the eligibility criterion of
minimum alpha angle from 60 to 55. This included 21
more participants from the adult care center, and there was
a slight increase from 18% to 25.4% in the proportion of sub-
jects definitely willing to participate. A previous prospec-
tive assessment study on willingness to participate in a
comparable randomized trial for the treatment of meniscal
tears found a similar proportion of 22% of potential subjects
who were definitely willing to participate in the trial.3 The
prospective assessment predicted quite accurately the 26%
of eligible patients who participated in the actual rando-
mized trial.7
Analysis of the association of stated willingness to partic-
ipate and treatment preferences in the adult care center
group revealed a significant relationship consistent with
findings from other studies.3 Amajority of the patients with
stronger treatment preferences, as well as those with pre-
ference for surgery, were less willing to participate in the
randomized trial (Table 3). As expected, patients who favor
one treatment arm highly over another will likely find the
randomization process disturbing because they could be
given the less-wanted treatment. Nevertheless, our data
suggest that patients with definite treatment preferences
are in the minority (Tables 3 and 5). With respect to surgi-
cal treatment, it is not surprising that more of those with
preference for this were less willing to be in a randomized
study. We found that most of the patients had already tried
conservative treatment methods and felt they were ineffec-
tive. In another feasibility study of an RCT for FAI treat-
ment done in the United Kingdom, it was found that
although more patients were troubled about their risk of
developing OA than their current symptoms, patients were
not willing to continue with nonsurgical management for
more than 6 months if their symptoms had not improved.9
This demonstrates how crucial patients’ equipoise is in
enrolling for a trial comparing 2 treatment arms. A
balanced perception of the risks and benefits of both treat-
ment methods may not only enhance enrollment rates but
also minimize the incidence of cross-overs and dropouts.
It is also possible that greater understanding of treat-
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Figure 1. Willingness to participate in different groups.
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in the randomized trial. Given the recent growing interest
in the etiology, treatment, and treatment outcomes of FAI
deformities, there is an expanding base of knowledge avail-
able to patients and surgeons alike. A person may learn of
the advantages or pitfalls of one treatment approach as
compared with others, leading to consolidation of a treat-
ment preference. This trend will have an effect on the
implementation of high–evidence level studies on FAI
treatment outcomes. It is therefore important that an RCT
is undertaken now while it is feasible.
The findings of this study show that participant accrual
for a randomized trial comparing treatments for FAI is
currently achievable. Waiting on this may be detrimental
to the successful implementation of the trial, as treatment
preferences seem to influence willingness to participate in
the trial. Our findings, with respect to inclusion criteria
and regional variations in patient populations, will influ-
ence the design of a planned randomized trial to maximize
enrollment.
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